CO2 Injector Market to reach US$ 21,520.3 thousand by 2033 as Demand for Outpatient Procedures Rises Worldwide | Future Market Insights, Inc.
The United States CO2 injector market is set to expand at a CAGR of 6.5% & The CO2 injector market in the United Kingdom is projected to witness a CAGR of 6.2% in the estimated period 2023 to 2033.
NEWARK, Del, Oct. 24, 2023 (GLOBE NEWSWIRE) -- From 2023 to 2033, the global CO2 injector market is projected to grow at a compound annual growth rate of *6.2%*. In 2023, the market is expected to be valued at *US$ 11,756.2 thousand*.By the end of 2033, its estimated valuation will be *US$ 21,520.3 thousand*. In 2023, the demand for CO2 injectors is projected to grow by *5.5%* year over year.
The emergence of CO2 injectors as a technology for angiography presents a significant opportunity to revolutionize the landscape of outpatient procedures. CO2 injectors have an excellent safety record, improving patient well-being and preparing the way for more efficient and streamlined outpatient care. This possibility has far-reaching ramifications, relieving hospital resource constraints, improving patient experiences, and transforming the healthcare delivery paradigm.
*Get a Sample Copy of the Report:* https://www.futuremarketinsights.com/reports/sample/rep-gb-18012
Several angiography procedures using iodinated contrast agents have necessitated hospital stays or extended periods of post-procedural observation due to the risk of adverse reactions. However, CO2 injectors have shown a distinct advantage in reducing the risk of allergic reactions and nephrotoxicity, as CO2 is a natural component of the human body. This inherently safer nature of CO2 angiography minimizes patient discomfort and allows for quicker patient recovery.
The prospect of more outpatient procedures is particularly significant in the context of contemporary healthcare demands. Overcrowded hospitals and lengthy patient stays can strain healthcare resources, drive up costs, and lead to delayed patient care access. CO2 injectors could mitigate these challenges by facilitating procedures that allow patients to return home sooner, freeing up hospital beds and resources for more critical cases.
CO2 injectors, in contrast, are set to eliminate the risk of direct nephrotoxic effects. Carbon dioxide is expected to prevent kidney damage as it is rapidly absorbed, metabolized, and exhaled. This inherent safety advantage positions CO2 angiography as a viable alternative for at-risk patients due to compromised renal health.
The reduction in nephrotoxicity is also expected to streamline post-procedural care. Patients undergoing CO2 angiography are spared the need for extensive hydration regimens aimed at flushing out contrast agents from their systems, simplifying the recovery process.
*Key Takeaways:*
· The global CO2 injector market recorded a CAGR of 4.7% in the historical period from 2018 to 2022.
· The United States is set to expand at a CAGR of 6.5% in the forecast period.
· China is estimated to showcase a CAGR of 8.2% in the review period with rising investments in healthcare infrastructure and technology.
· India will likely record a CAGR of 8.0% from 2023 to 2033 in the market.
· Based on products, the automated CO2 injection system segment is projected to retain its dominance through 2033 at a CAGR of 6.6% in the market.
· The interventional radiology segment is set to showcase a significant CAGR of 7.1% through 2033 in terms of application.
* “The market for CO2 angiography is anticipated to benefit from the growing emphasis on environmental sustainability and the decrease of medical waste. Due to its ability to reduce environmental effects by facilitating the body's simple removal of carbon dioxide, it is expected to be in high demand among clinicians. This is probably going to help the healthcare industry achieve its sustainability targets, which will increase demand,”** *opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
*CO2 Injectors Market Report Coverage:*
*Attribute* Details
*CO2 Injector Market Estimated Size (2023)* US$ 11,756.2 thousand
*CO2 Injector Market Projected Size (2033)* US$ 21,520.3 thousand
*Value-based CO2 Injector Market CAGR (2023 to 2033)* 6.2 %
*Forecast Period* 2023 to 2033
*Historical Data Available for* 2018 to 2022
*CO2 Injector Market Analysis* Value (US$ thousand)
*Key Country Covered in CO2 Injector Market* North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa
*Key States Covered in CO2 Injector Market* United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa.
*Key Segments Covered in CO2 Injector Market* By Product, By Application, By End User, By Region
*Key Companies Profiled in CO2 Injector Market* · Angiodroid
· Malek Medical GmbH
· Optimed
*CO2 Injector Market Report Coverage* Market Forecast, Competition Intelligence, Market Dynamics and Challenges, Strategic Growth Initiatives
*Unlock Optimal Health Today! Discover Exclusive CO2 Injector Market Analysis with Special Discounts. Act Now:* https://www.futuremarketinsights.com/checkout/18012
*Competitive Landscape:*
Renowned players are setting up shop to get a presence in the fiercely contested CO2 injector industry. Several manufacturers are using innovation in technology and product development as a major strategy.
Companies are also investing in research and development to create CO2 injectors that are more efficient and environmentally responsible. These innovations benefit a larger range of industries, from energy production to agriculture, as they lower operational costs while also reducing greenhouse gas emissions.
*For instance,*
· A new cath lab at St. Isabel's Hospital in Mylapore started a soft opening in March 2023. The new facility will manage heart emergencies and offer patients 24/7 coronary intervention services. Interventional radiology and interventional neurology operations will be carried out in the lab.
· Angiodroid declared the successful completion of its US$ 5.93 million Series A fundraising round in February 2023. Through strategic partnerships and financial investments in the sales force, it seeks to strengthen its international expansion. Additionally, it would concentrate on enabling CO2 angiography for millions of patients worldwide.
*CO2 Injector Market Segmentation:*
*By Product:*
· Automated
· Semi-automated
*By Application:*
· Peripheral Angiography
· Interventional Radiology
· Vascular Surgery
· Interventional Cardiology
*By End User:*
· Hospitals
· Independent Cath Laboratories
*By Region:*
· North America
· Latin America
· Europe
· South Asia
· East Asia
· Oceania
· Middle East and Africa*Author By:*
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
*Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:*
Angiography Devices Industry Outlook: The global market is expected to reach a valuation of US$ 12,717.9 million in 2023.
CO2 Medical Laser Systems Industry Sales: The global market is set to reach US$ 550.01 million in 2023.
Contrast Media Injectors Industry Trends: The global market was valued at US$ 1.5 Billion in 2022 and is expected to reach US$ 3 Billion by 2033, finds Future Market Insights (FMI) in a recent market survey.
Interventional Cardiology Devices Industry Revenue: Global demand is anticipated to record a CAGR of 8.4% during the forecast period (2022 to 2032).
Single Dose Radiotherapy Services Industry Growth: The global market is expected to attain a valuation of US$ 7.88 billion in 2023 and is projected to reach US$ 16 billion by 2033, expanding at a CAGR of 7.3% during the forecast period.
*About Future Market Insights (FMI) *
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
*Contact Us: *
Nandini Singh Sawlani* *
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
*For Sales Enquiries: *sales@futuremarketinsights.com
*Website:* https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube